His lab is focusing on refining the alanine-scanning assay to a couple important residues that could precisely distinguish among fibrils from neurodegenerative tauopathies. He envisions applying this streamlined assay for postmortem neuropathological diagnosis, And maybe for blood screening of tauopathies.Similarly, in co-cultures of rat primary ce